Follow-The-Filings

Security · featured owners

COYA Coya Therapeutics Inc.

Health Care COMMON STOCK Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.4%
  • $14M

COYA (Coya Therapeutics Inc.) is held in 1 featured 13F book as of 2026 Q2. David Einhorn - DME Capital Management is the largest tracked holder by portfolio weight (0.35%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.4% (David Einhorn - DME Capital Management) · not free-float ownership

  1. David Einhorn 0.35%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
David Einhorn - DME Capital Management 2026 Q2 0.35% Hold 2,335,540 $14M History

1 current · options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K/A 5.02 Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
424B3 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 1.01,3.02,7.01,8.01,9.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,7.01,9.01 Filing Doc
10-Q Filing Doc
424B5 Filing Doc
8-K 1.01,3.02,7.01,9.01 Filing Doc
424B5 Filing Doc
8-K 8.01 Filing Doc
424B7 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 4 rows shown

Filed Form Detail Links
4 Period Apr 9, 2026 Filing Doc
4 Period Jan 22, 2026 · 4 forms Filing Doc
4 Period Jan 2, 2026 · 5 forms Filing Doc
4 Period Aug 18, 2025 Filing Doc

Updated 13 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $6M $3.55M $7.95M
Net income -$7.99M -$14.88M -$21.23M
Net margin * -133.1% -418.7% -267.1%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $41.2M $44.31M $49.94M
Total non-current assets * $65,949 $38,588 $11,227
Total assets $41.26M $44.35M $49.95M
Total current liabilities $5.05M $3.82M $5.87M
Total non-current liabilities * $0.575M $0.945M $1.05M
Total equity $35.64M $39.58M $43.03M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$11.19M -$10.29M -$10.74M
Cash from investing -$0.543M -$0.025M -$1.16M
Cash from financing $38.43M $16.03M $20.39M
Net change in cash * $26.69M $5.71M $8.48M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders